世界最新医学信息文摘（连续型电子期刊）
世界最新醫學信息文摘（連續型電子期刊）
세계최신의학신식문적（련속형전자기간）
World Latest Medicine Information
2015年
47期
121-122
,共2页
肺癌%肿瘤标志物%临床病例诊断%临床分期
肺癌%腫瘤標誌物%臨床病例診斷%臨床分期
폐암%종류표지물%림상병례진단%림상분기
Lung cancer%tumor markers%clinical diagnosis%clinical stage
目的 探究肺癌的肿瘤标志物与临床病理诊断效果.方法 选取我院2012年12月至2015年3月收治的148例接受抗肿瘤治疗的患者,采用CYFRA21-l、CEA以及NSE等血清肿瘤标志物对患者进行检验,随机将患者分为实验组和对照组,实验组80例,对照组68例.分析两组患者肿瘤标志物水平对比情况.结果 对照组和实验组肺癌肿瘤患者的年龄、性别、病例分型等方面比较差异无统计学意义(P>0.05),实验组患者3中血清肿瘤标志物水平明显高于对照组,差异有统计学意义(P<0.05).结论 肺癌患者肿瘤标志物升高相较于对照组临床分期晚,对照组患者肿瘤标志物3种血清水平明显低于实验组,说明肿瘤标志物可作为临床病例评估肺癌患者,准确率较高,是患者治疗肺癌的重要指示.
目的 探究肺癌的腫瘤標誌物與臨床病理診斷效果.方法 選取我院2012年12月至2015年3月收治的148例接受抗腫瘤治療的患者,採用CYFRA21-l、CEA以及NSE等血清腫瘤標誌物對患者進行檢驗,隨機將患者分為實驗組和對照組,實驗組80例,對照組68例.分析兩組患者腫瘤標誌物水平對比情況.結果 對照組和實驗組肺癌腫瘤患者的年齡、性彆、病例分型等方麵比較差異無統計學意義(P>0.05),實驗組患者3中血清腫瘤標誌物水平明顯高于對照組,差異有統計學意義(P<0.05).結論 肺癌患者腫瘤標誌物升高相較于對照組臨床分期晚,對照組患者腫瘤標誌物3種血清水平明顯低于實驗組,說明腫瘤標誌物可作為臨床病例評估肺癌患者,準確率較高,是患者治療肺癌的重要指示.
목적 탐구폐암적종류표지물여림상병리진단효과.방법 선취아원2012년12월지2015년3월수치적148례접수항종류치료적환자,채용CYFRA21-l、CEA이급NSE등혈청종류표지물대환자진행검험,수궤장환자분위실험조화대조조,실험조80례,대조조68례.분석량조환자종류표지물수평대비정황.결과 대조조화실험조폐암종류환자적년령、성별、병례분형등방면비교차이무통계학의의(P>0.05),실험조환자3중혈청종류표지물수평명현고우대조조,차이유통계학의의(P<0.05).결론 폐암환자종류표지물승고상교우대조조림상분기만,대조조환자종류표지물3충혈청수평명현저우실험조,설명종류표지물가작위림상병례평고폐암환자,준학솔교고,시환자치료폐암적중요지시.
Objective: To explore the effect of tumor markers and clinical pathological diagnosis of lung cancer.Methods:Selected in our hospital in December 2012 and 2015 March were 148 cases accept antitumor therapy were treated with CY-FRA21-1, CEA and NSE of serum tumor markers of patients tested randomly were divided into the experimental group and the control group, the experimental group 80 cases in the control group (n = 68). The level of tumor markers in the two groups was analyzed.Results: In the control group and experimental group lung cancer patients' age, gender, case classification and difference no statistical significance (P>0.05). Patients in the experimental group 3 in serum tumor signs were significantly higher than those in the control group, the difference was statistically significant (P<0.05).Conclusion:Patients with lung cancer markers were in-creased compared with the control group, late clinical stage, patients in the control group tumor markers three kinds of serum level was significantly lower than that of the experimental group, tumor marker compounds as clinical evaluation for patients with lung cancer, high accuracy, is the important instructions of treatment in patients with lung cancer.
